In-depth cellular and humoral dynamics of the response to COVID-19 vaccine booster in patients with chronic B-cell neoplasms

In-depth cellular and humoral dynamics of the response to COVID-19 vaccine booster in patients with chronic B-cell neoplasms

Bibliographic Details
Main Authors:	Emily Ayers, Glenda Canderan, Michael E. Williams, Behnam Keshavarz, Craig A. Portell, Jeffrey M. Wilson, Judith A. Woodfolk
Format:	Article
Language:	English
Published:	Nature Publishing Group 2023-07-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-023-00884-w

Similar Items

Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients
by: Jakub Wroński, et al.
Published: (2022-10-01)

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination
by: Saskia van der Lee, et al.
Published: (2018-04-01)

The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients
by: Jakub Wroński, et al.
Published: (2023-02-01)

Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in Elderly
by: Daniela Dalla Gasperina, et al.
Published: (2023-09-01)

Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice
by: Feng-Xia Gao, et al.
Published: (2022-12-01)

Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
by: Masashi Nishikubo, et al.
Published: (2023-01-01)

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adultsResearch in context
by: Constanza Méndez, et al.
Published: (2023-05-01)

Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection
by: Hakjun Hyun, et al.
Published: (2023-03-01)

HUMORAL IMMUNITY TO HUMAN NEOPLASMS
by: D. Shadafza, et al.
Published: (1974-09-01)

Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profiling
by: Jingwen Ai, et al.
Published: (2022-10-01)

Formation of humoral and cellular immunity to measles vaccine in adults
by: A. P. Toptygina, et al.
Published: (2020-04-01)

COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies
by: Laura Gragnani, et al.
Published: (2022-01-01)

Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysis
by: Miriam Hernández-Porto, et al.
Published: (2022-09-01)

P1534: MRNA-1273 SARS-COV-2 VACCINE IN RECENTLY TRANSPLANTED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: CELLULAR AND HUMORAL IMMUNE RESPONSES AND BOOSTER EFFECT
by: Nil Albiol, et al.
Published: (2023-08-01)

Effectiveness of Booster Dose of Anti SARS-CoV-2 BNT162b2 in Cirrhosis: Longitudinal Evaluation of Humoral and Cellular Response
by: Vincenzo Giambra, et al.
Published: (2022-08-01)

Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster
by: Montserrat Torres, et al.
Published: (2022-11-01)

Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients
by: Isabel Pérez-Flores, et al.
Published: (2023-02-01)

Cellular and humoral immunity in children with asthma
by: V. M. Dudnyk, et al.
Published: (2017-02-01)

Cellular and humoral immunity in children with asthma
by: V. M. Dudnyk, et al.
Published: (2017-02-01)

The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
by: Florian D. Hastert, et al.
Published: (2022-05-01)

Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies
by: Line Dam Heftdal, et al.
Published: (2023-12-01)

SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
by: Eun Kim, et al.
Published: (2023-06-01)

Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human
by: Yuwei Zhang, et al.
Published: (2022-10-01)

Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response
by: Sammy Patyna, et al.
Published: (2022-04-01)

HUMORAL AND CELLULAR IMMUNITY FACTORS IN MYOCARDIAL INFARCTION
by: V. I. Seledtsov, et al.
Published: (2014-07-01)

Association between Adverse Reactions and Humoral Immune Response No Longer Detectable after BNT162b2 Booster Vaccination
by: Stilla Bauernfeind, et al.
Published: (2022-09-01)

Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections
by: Salomé Desmecht, et al.
Published: (2022-05-01)

Characterization of humoral and cellular immune features of gamma-irradiated influenza vaccine
by: Fengjia Chen, et al.
Published: (2021-02-01)

Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity
by: Sietske K. Rosendahl Huber, et al.
Published: (2019-01-01)

Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases
by: Meng Wang, et al.
Published: (2023-11-01)

Peptide vaccines designed with the aid of immunoinformatic against Caseous Lymphadenitis promotes humoral and cellular response induction in mice.
by: Daniela Droppa-Almeida, et al.
Published: (2021-01-01)

Humoral and cellular immunity to RSV in infants, children and adults
by: Green, C, et al.
Published: (2018)

Comparison of pneumococcal conjugate vaccine (PCV-13) cellular immune responses after primary and booster doses of vaccine
by: Timothy J. Chapman, et al.
Published: (2020-12-01)

Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective single-centre cohort study
by: Tobias Silzle, et al.
Published: (2023-06-01)

SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series
by: Chapin S. Korosec, et al.
Published: (2024-04-01)

Heterologous Booster Immunization Based on Inactivated SARS-CoV-2 Vaccine Enhances Humoral Immunity and Promotes BCR Repertoire Development
by: Xinghang Li, et al.
Published: (2024-01-01)

Comparable antigen-specific T cell responses in vaccinees with diverse humoral immune responses after the primary and booster BBIBP-CorV vaccination
by: Dong Wei, et al.
Published: (2022-12-01)

Humoral Effect of SARS-CoV-2 mRNA vaccination with booster dose in solid tumor patients with different anticancer treatments
by: Chiara Piubelli, et al.
Published: (2023-02-01)

Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults.
by: Vania Giacomet, et al.
Published: (2018-01-01)

Anti-Ad26 humoral immunity does not compromise SARS-COV-2 neutralizing antibody responses following Gam-COVID-Vac booster vaccination
by: Maria G. Byazrova, et al.
Published: (2022-11-01)